Creating new life forms that may help eradicate cancer affecting women

Feb 26, 2007

Instead of using the usual cancer-fighting modalities, surgery, chemotherapy, or radiation, researchers from a drug development company called Advaxis, have embarked on a novel approach to fighting cancer: Engaging the immune system to attack cancer in the same the way it would a flu vaccine, by creating new life forms.

Dr. Vafa Shahabi, Advaxis' Director of Research and Development, reports that because the human immune system is not designed to fight cancer on its own, she and her colleagues are trying to harness its power through a new kind of life form: specifically a family of vaccines, which they call Lovaxin. The vaccines are comprised of new strains of bacteria created in Advaxis' laboratory that are programmed to kill off specific cancers.

The Key: A Microbe Found in Dairy Products

Central to this startling discovery is the microbe Listeria monocytogenes, a common bacterium found in milk, cheese and other dairy products. This microorganism apparently aids in fighting cancer by activating the body's own killer (cytotoxic T) cells to elicit a stronger than normal immune response to the presence of cancer cells. The vaccines "teach" the immune system to mount a specialized, targeted response that is lethal to cancer.

When Listeria is introduced in the body, it has a powerful, direct stimulatory effect on the activities of tumor-killing T cells. "Essentially the modified Listeria vaccines harness the power of the immune system against this infectious agent," explains Dr. Shabahi, "and then directs it to successfully attack cancer cells. The bacterium in effect then becomes a cancer-fighting 'Trojan horse,' with the enemy tucked inside."

For breast cancer, Dr. Shababi's team fused Listeria with a tumor-associated protein, HER-2/Neu, to immune cells, to create a vaccine called Lovaxin B. What these cells do is enlist killer T cells to seek and destroy tumor cells that over-express the HER-2/Neu molecule. This is significant because HER-2/Neu is over- expressed in 20%- 40% of all breast cancers.

Source: Advaxis, Inc.

Explore further: Cell mechanism discovered that may cause pancreatic cancer

add to favorites email to friend print save as pdf

Related Stories

Sheriffs want popular police-tracking app disabled

2 minutes ago

Sheriffs are pressuring Google Inc. to turn off a feature on its Waze traffic software that warns drivers when police are nearby. They say one of the technology industry's most popular mobile apps could put ...

Warm ocean melting East Antarctica's largest glacier

17 minutes ago

The largest glacier in East Antarctica, containing ice equivalent to a six-metre (20-foot) rise in global sea levels, is melting due to warm ocean water, Australian scientists said on Monday.

British lawmakers demand freeze on fracking

17 minutes ago

A committee of British lawmakers demanded a national moratorium on fracking due to environmental concerns on Monday, ahead of a crucial vote intended to boost the shale gas industry.

China's online population nears 650 million

18 minutes ago

The number of Internet users in China has risen to nearly 650 million, authorities said over the weekend, as the world's largest online population continues to rise.

Obama recommends extended wilderness zone in Alaska

11 hours ago

US President Barack Obama said Sunday he would recommend a large swath of Alaska be designated as wilderness, the highest level of federal protection, in a move likely to anger oil proponents.

Recommended for you

Lung cancer clues found in downstream pathway

11 hours ago

Despite the promise of the gene KRAS as a target for treating lung cancer, finding effective therapies has been challenging. Now researchers are traveling down the pathway to find what makes KRAS cancerous.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.